ARTERIOSCL THROM VAS 润色咨询

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

出版年份:1995 年文章数:4400 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
14.1 %
年文章数
4400
期刊官网
点击查看 (点击次数:12727)
点击查看 (点击次数:4316次)
作者需知
点击查看 (点击次数:573次)
期刊简介
稿件收录要求

About Arteriosclerosis, Thrombosis, and Vascular Biology

The journal Arteriosclerosis, was started in 1981 by Edwin L. Bierman, Arno Motulsky, Russell Ross, Lawrence A. Harker, Paul Bornstein, James G. White and Goran Bondjers. It was published bi-monthly until January 1992, when it began monthly publication.

Dr. Bierman continued as Editor-in-Chief until December, 1990.

Alan Fogelman took over as Editor-in-Chief in January 1991. Jack Hawiger was a co-editor. Goran Bondjers also stayed on the masthead as an editor. Also in January of 1991, the title expanded to Arteriosclerosis & Thrombosis. The title then changed to Arteriosclerosis, Thrombosis and Vascular Biology in January 1995.

James Scott and Giulio Gabbiani were added as editors in January 1995.

Donald D. Heistad, took over as Editor-in-Chief in July 1999.

Goran Hanson joined as European Editor and Akira Takeshita joined as the Asian Editor. Christer Betsholtz, Ingemar Bjorkhem, Per Eriksson, Frank Faraci, William Haynes, Steven Lentz, Ryozo Nagai, Anders Olsson, Mats Rudling, and Arthur Spector were Associate Editors working at this time.

Mark Taubman became Editor-in-Chief in July 2007. Alain Tedgui became the European Editor and Ryozo Nagai became the Asian Editor. They were assisted by Associate Editors: Edward Fisher, Chantal Boulanger, Francois Cambien, M. John Chapman, Joseph Emmerich, Catherine Hedrick, Ziad Mallat, Nigel Mackman, Ruth McPherson, Joseph Miano and William Sessa.

Edward Fisher became Editor-in-Chief in July 2011 and maintained the Editorial teams of the previous Editorship.

Alan Daugherty became Editor-in-Chief in July 2012. His Senior team consisted of Daniel Rader, Ann Marie Schmidt, Robert Hegele, Nigel Mackman and Christian Weber. They were assisted by Associate Editors: Michelle Albert, Chantal Boulanger, Mat Daemen, Jie Du, Mark Majesky, Ziad Mallat, Ruth McPherson, Peter Newman, Janet Powell, Hiroaki Shimokawa and Renu Virmani.

Ann Marie Schmidt became Editor-in-Chief in July 2022. Her current Editorship information is available at our Editorial Board page.

ATVB editors

Pictured left to right: Editor Emeriti, Dr. Donald D. Heistad, current Editor-in-Chief, Dr. Alan Daugherty, Editor Emeriti, Dr. Edward Fisher and Editor Emeriti, Dr. Alan Fogelman

ATVB General Statistics

Editor-in-Chief: Ann Marie Schmidt, MD

Managing Editor: Melissa LN Arey

Editorial Office Address:

ATVB
7272 Greenville Ave
Dallas, TX 75231
atvb@atvb.org

Frequency: Monthly

Audience: Academic cardiologists, vascular biologists, physiologists, pharmacologists, and hematologists

Pages per year: 2,875

Review Process: Peer-reviewed

Manuscript Acceptance Rate: 18%

Lead Times for Original Research Articles: Submission to 1st Decision: 13.9 days; Acceptance to Online Publication: 14.4 days; Acceptance to Print Publication: 50.5 days

Circulation: Over 15,400

Supplements: Yes

Indexed in: BIOSIS, CABS, Chemical Abstracts, Current Contents, EMBASE, Scopus and MEDLINE and PUBMED